Skip to main content
Bio-TechneRevenue

TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances

Source: Autobound Signal API · 80 signals tracked for Bio-Techne · updated

Get Bio-Techne's live signals in Claude or ChatGPT, or by API

AskWhat changed at Bio-Techne this week? Use Autobound signals for bio-techne.com.

What happened

Bio-Techne Corporation reported net sales of $299.7 million for the first quarter of fiscal 2027.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Bio-Techne Corporation TECH reported adjusted earnings per share (EPS) of 44 cents for the first quarter of fiscal 2027, up 4.8% year over year. The figure surpassed the Zacks Consensus Estimate by 10%. The quarter's adjustments excluded amortization of intangible assets, acquisition-related expenses, stock-based compensation, restructuring costs and certain litigation charges, among others. GAAP EPS was 18 cents compared with 24 cents in the prior-year quarter. Net sales totaled $299.7 million, up 5% year over year on a reported basis and 7% on an organic basis. The figure surpassed the Zacks Consensus Estimate by 2.3%. Foreign currency had an immaterial impact, while a business held for sale had an unfavorable impact of 2%. Consumables revenues increased 2.4% year over year to $237.3 million, while instrument revenues rose 16.8% to $25.5 million. Services revenues declined 18.3% to $22.5 million. Royalty revenues surged to $14.5 million from $5.6 million in the year-ago period. Within Protein Sciences, Bio-Techne recorded revenues of $219.7 million, up 9% year over year from $202.2 million. Organic revenues also increased 9%, while foreign currency had an immaterial impact. The segment's operating margin contracted 50 basis points (bps) to 37.9% from 38.4% in the prior-year quarter. Segment operating income increased to $83.2 million from $77.7 million a year ago...

Keep reading with a free account

The rest of this article, and every signal for Bio-Techne, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Revenue

What this signalsRevenue results often set the next budget cycle.

Amount named
$300M

The full record

From the Signal API record

Numbers

Amount named in the story
$300M

Extraction

Confidence
95%
Detected
Nov 9, 2026
signal_type
news
signal_subtype
has_revenue

Use this data

Get every revenue signal for Bio-Techne and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”

  2. Send it to your own tools

    The Signal API returns revenue signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/57236cd6-40e8-c906-4e3a-9f5f10afc3c7 returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.

{
  "signal_id": "57236cd6-40e8-c906-4e3a-9f5f10afc3c7",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-11-09T12:50:00+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "url": "https://finance.yahoo.com/healthcare/articles/tech-q1-earnings-revenues-beat-125000590.html",
    "title": "TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances - Yahoo Finance",
    "excerpt": "Bio-Techne Corporation TECH reported adjusted earnings per share (EPS) of 44 cents for the first quarter of fiscal 2027, up 4.8% year over year. The figure surpassed the Zacks Consensus Estimate by 10%. The quarter's adjustments excluded amortization of intangible assets, acquisition-related expenses, stock-based compensation, restructuring costs and certain litigation charges, among others. GAAP EPS was 18 cents compared with 24 cents in the prior-year quarter. Net sales totaled $299.7 million, up 5% year over year on a reported basis and 7% on an organic basis. The figure surpassed the Zacks Consensus Estimate by 2.3%. Foreign currency had an immaterial impact, while a business held for sale had an unfavorable impact of 2%. Consumables revenues increased 2.4% year over year to $237.3 million, while instrument revenues rose 16.8% to $25.5 million. Services revenues declined 18.3% to $22.5 million. Royalty revenues surged to $14.5 million from $5.6 million in the year-ago period. Within Protein Sciences, Bio-Techne recorded revenues of $219.7 million, up 9% year over year from $202.2 million. Organic revenues also increased 9%, while foreign currency had an immaterial impact. The segment's operating margin contracted 50 basis points (bps) to 37.9% from 38.4% in the prior-year quarter. Segment operating income increased to $83.2 million from $77.7 million a year ago, reflecting...",
    "summary": "Bio-Techne Corporation reported net sales of $299.7 million for the first quarter of fiscal 2027.",
    "planning": false,
    "image_url": "https://s.yimg.com/lo/mysterio/api/08d7395e6b931ce09347b5ce4ee5243acc4d364ca259900e93ed447c8738031b/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fzacks.com%2F955c0f2ed0992898cedf76a9efa5b1f2.jpg",
    "confidence": 0.95,
    "published_at": "2026-11-09T12:50:00Z",
    "article_sentence": "Net sales totaled $299.7 million, up 5% year over year on a reported basis and 7% on an organic basis.",
    "amount_normalized": 299700000
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.